气道上皮源性细胞因子在哮喘中的作用
综述阐述气道上皮与吸入环境相互作用对哮喘病理生物学的重要性,重点介绍IL-25、IL-33和胸腺基质淋巴细胞生成素(TSLP)作为上皮源性警报素在哮喘发病机制中的作用。现有最佳证据支持TSLP:结合TSLP并阻止其与受体结合的人源单克隆抗体可缓解过敏性哮喘患者气道炎症并减轻过敏原诱导的气道反应。深入理解这些警报素的作用可能促进哮喘新疗法开发。
要点
- IL-25、IL-33和TSLP是气道上皮源性警报素,参与哮喘发病。
- TSLP证据最充分:抗TSLP单抗可缓解过敏性哮喘气道炎症。
- 抗TSLP单抗可减轻过敏原诱导的气道反应。
核心结论
- 气道上皮源性警报素IL-25、IL-33和TSLP参与哮喘病理生物学,其中TSLP证据最充分。
- 结合TSLP并阻止其与受体结合的人源单克隆抗体可缓解过敏性哮喘气道炎症并减轻过敏原诱导的气道反应。
- 深入理解上皮源性警报素的作用可能促进哮喘新疗法开发。
研究设计与样本
- 综述,围绕气道上皮与吸入环境相互作用及上皮源性细胞因子在哮喘中的作用进行阐述。
主要发现
- IL-25、IL-33和TSLP三种上皮源性警报素均被牵涉于吸入过敏原诱导气道反应的病理生物学。
- TSLP证据最佳:人源单克隆抗体结合TSLP并阻止其与受体结合,可缓解过敏性哮喘患者气道炎症。
- 该抗TSLP单克隆抗体可减轻过敏原诱导的气道反应。
临床怎么用
- 关注上皮源性警报素通路,尤其是TSLP,作为过敏性哮喘的潜在治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The interaction between the airway epithelium and the inhaled environment is crucial to understanding the pathobiology of asthma. Several studies have identified an important role of airway epithelial-derived cytokines, IL-25, IL-33, and thymic stromal lymphopoietin (TSLP) in asthma pathogenesis. These cytokines have been described as epithelial-derived alarmins that activate and potentiate the innate and humoral arms of the immune system in the presence of actual or perceived damage. Each of the three epithelial-derived alarmins has been implicated in the pathobiology of inhaled allergen-induced airway responses. The best evidence to date exists for TSLP, in that a human monoclonal antibody, which binds TSLP and prevents its engagement with its receptor, resolves airway inflammation in patients with allergic asthma and attenuates allergen-induced airway responses. Better understanding the roles that the epithelial-derived alarmins play and how they influence airway immune response may allow the development of novel therapeutics for asthma treatment.
引用
- Mitchell PD, O'Byrne PM. Epithelial-Derived Cytokines in Asthma. Chest. 2016. PMID: 27818325. doi:10.1016/j.chest.2016.10.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。